Shares of VAT Group currently lead the performance charts among domestic blue-chip equities in Switzerland, drawing enthusiastic buy recommendations from major financial institutions including Barclays, UBS, and Vontobel. The Basler Kantonalbank recently joined this bullish consensus when analyst Corina Hennig leveraged a recent price weakness driven by corporate figures to upgrade her investment rating from market weight to overweight. Hennig maintains her price target at 700 francs for the vacuum valve manufacturer based in the Rhine Valley.
The analyst regards the subdued market reaction to last week's incoming orders as exaggerated. During the third quarter, the company reported incoming orders totaling 697 million francs, significantly outperforming average analyst projections of 525 million francs. Backed by exceptionally robust order books, the enterprise anticipates that next year's revenue will substantially exceed the previously forecasted range of 1.5 billion to 1.7 billion francs, though management remains cautious about providing precise forward-looking figures at this stage.
Contrasting sharply with the prevailing bullish sentiment among analysts, Utsav Sinha of AlphaValue holds a dissenting view. Back in July, the London-based analyst issued a sell rating on VAT Group shares alongside a price target of 639 francs, at a time when the prominent outperformer traded slightly above 660 francs, reflecting a 58 percent gain since January within the 30-member Swiss Leaders Index.
Currently, the AlphaValue analyst rates the stock as reduce, representing a softer bearish recommendation. However, he has adjusted his price target downward to 615 francs. According to available reports, Sinha remains the sole representative in his professional field advocating the sale of the vacuum valve maker's equities. He indicated plans to slightly upwardly revise his earnings estimates for the upcoming year based on the released financial statements, though his commentary contains no indication of an impending rating revision.
Meanwhile, UBS has recorded continued success with its European small and mid-cap strategy known as the Top 20 List. Achieving a gain of 18.6 percent since January, the favored selection notably outperforms its benchmark index, which advanced by roughly 9 percent over the same period. In a newly circulated strategy document, authors led by Natasha Brilliant implemented a comprehensive restructuring of the portfolio. Newly added equities include Basic-Fit, De'Longhi, GEK Terna, Salzgitter, Scout24, and Siltronic, alongside Swiss names Huber+Suhner and Inficon. Conversely, positions in Brunello Cucinelli, Delivery Hero, Inchcape, Nexans, Standard Life, Savills, Theon International, and Zealand Pharma were removed from the selection.
With these modifications, four Swiss equities now feature within the UBS European small and mid-cap selection, a composition managed by teams stationed in London. Based on price projections formulated by internal analysts, Huber+Suhner shares exhibit the highest prospective upside at 94 percent, carrying a buy rating and a twelve-month target of 300 francs. Implenia follows with a calculated upside potential of 61 percent under a buy rating and a 100-franc target, while Accelleron presents a 37 percent upside with a buy rating and a 93-franc target. Inficon rounds out the domestic selections with an estimated upside potential of nearly 23 percent, supported by a buy rating and a twelve-month target of 215 francs.
